Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Local therapy improves overall survival in patients with clinically lymph node-positive prostate cancer, a meta-analysis suggests.
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
Bariatric surgery is associated with a lower risk of hematologic cancer in women, a study suggests.
Diabetes increases the likelihood of upstaging in patients with clinical T1 RCC undergoing partial or radical nephrectomy, a study suggests.
Gilead has discontinued the ENHANCE-2 study, which was designed to evaluate magrolimab in AML patients with TP53 mutations.
In a recent survey, 70% of cancer patients said they use complementary or alternative medicine as part of their cancer care.
Researchers say they have identified which patients with rhabdomyosarcoma are most likely to benefit from radiotherapy.
Good oral health is associated with improved survival in patients with head and neck cancer, a study suggests.
The FDA has approved bosulif (bosutinib) for patients aged 1 year or older with chronic phase Ph+ CML.
More than half of US adults surveyed said they “definitely” or “probably” won’t be vaccinated with one of the updated COVID-19 vaccines.
Researchers are evaluating the effects of adding atezolizumab to adjuvant treatment with trastuzumab emtansine in patients with HER2-positive breast cancer.
Researchers have found several differences in cancer rates between members of the US military and the general US population.
Researchers say they have identified genes that should be considered for gene panel testing in prostate cancer.
Patients with metastatic breast cancer who receive alpelisib in clinical practice have higher rates of hyperglycemia than patients who receive the drug in clinical trials, a new study suggests.
Combining neoadjuvant durvalumab with other agents improves response rates in patients with resectable non-small cell lung cancer.
Higher exposure to PFAS, phenols, and parabens is associated with previous cancer diagnosis in women but not men, a study suggests.
A Pfizer plant that makes drugs and hospital supplies has restarted production after a 10-week shutdown.
Researchers are conducting a phase 3 trial to compare Dato-DXd, with or without durvalumab, to investigator’s choice of treatment in patients with TNBC.
Privately-insured cancer patients living in states with restrictive telehealth policies were less likely to use telehealth in 2020 and 2021, a study showed.